Keyphrases
Platelet-derived Growth Factor Receptor (PDGFR)
100%
Fibroblast Growth Factor Receptor 1 (FGFR1)
100%
Rhabdoid Tumor
100%
Synergistic Efficacy
100%
Dual Targeting
100%
SWItch/Sucrose Non-fermentable
60%
Tumor Cells
40%
Receptor Tyrosine Kinase
40%
SMARCB1
40%
Apoptosis
20%
In Cancer
20%
ERK2
20%
Co-activation
20%
Acquired Resistance
20%
Clinical Specimens
20%
Tumor Patients
20%
Chemical Biology
20%
Dual Inhibitor
20%
Ponatinib
20%
Chromatin Remodelers
20%
FGFR Inhibitor
20%
PDGFR Inhibitor
20%
Pazopanib
20%
Inhibitor Combination
20%
Pediatric Cancer
20%
Molecular Profiling
20%
Combination Target
20%
Pharmacology, Toxicology and Pharmaceutical Science
Rhabdoid Tumor
100%
Fibroblast Growth Factor Receptor 1
100%
Malignant Neoplasm
60%
Receptor
40%
Protein Tyrosine Kinase
40%
Mitogen Activated Protein Kinase 3
20%
Ponatinib
20%
Pazopanib
20%
Biochemistry, Genetics and Molecular Biology